Chapter 118E of the general laws is hereby amended by adding at the end of SECTIN 77 the following new SECTION:
SECTION 78. To ensure appropriate and responsible use of drug testing, the office of Medicaid shall implement medical necessity documentation and utilization frequency guidelines, as outlined by the Centers for Medicare and Medicaid Services (CMS). The office of Mediciad shall require providers to demonstrate utilization and frequency control programs.
Notwithstanding any general or special law to the contrary an independent clinical laboratory that is the out-of-state and accredited by the College of American Pathologists shall be deemed eligible and qualified to participate as a masshealth provider and eligible for payment.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.